(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CARDIMAX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CARDIMAX

ST13

US500000079257697

Class

44

Filing

79257697

Registration

5917397

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

07/07/2026

Trademark type

Word

Nice classes

44

Filing date

03/12/2019

Registration date

11/26/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/12/2026

Last transaction

07/07/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

25

Owner location

CH

Examiner

GUROK, GALINA

Law office

N80

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Vifor Fresenius Medical Care Renal Pharma Ltd. (Vifor Fresenius Medical Care Renal Pharma AG)

Representatives

Marie Anne Mastrovito Womble Bond Dickinson (US) LLP

Technical classification

Nice Classes

Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 44

Medical services; hygienic and beauty care for human beings

Publications

History of USPTO decisions and trademark events.

37 publications found

C71T

CANCELLED SECTION 71

06/12/2026

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

11/26/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

10/24/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/24/2022

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

10/24/2022

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

10/24/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/24/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/24/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

10/24/2022

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/21/2021

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/10/2021

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

05/15/2020

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

03/16/2020

XXCR

GENERIC MADRID TRANSACTION CREATED

03/16/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

02/26/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

11/26/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/10/2019

PUBO

PUBLISHED FOR OPPOSITION

09/10/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/21/2019

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

08/03/2019

ALIE

ASSIGNED TO LIE

08/03/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/25/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/23/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/23/2019

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/16/2019

CNEA

EXAMINERS AMENDMENT MAILED

07/16/2019

XAEC

EXAMINER'S AMENDMENT ENTERED

07/15/2019

CNEA

EXAMINERS AMENDMENT -WRITTEN

07/15/2019

RFNT

REFUSAL PROCESSED BY IB

06/28/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

06/10/2019

RFRR

REFUSAL PROCESSED BY MPU

06/10/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

05/29/2019

CNSL

SUSPENSION LETTER WRITTEN

05/28/2019

DOCK

ASSIGNED TO EXAMINER

05/21/2019

MAFR

APPLICATION FILING RECEIPT MAILED

05/10/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/06/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

05/02/2019

Continuous trademark protection

Get notified about every new filing that threatens CARDIMAX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.